Glassman Wealth Services’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-89
| Closed | -$5.23K | – | 1977 |
|
|
2023
Q4 | $5.23K | Buy |
+89
| New | +$5.23K | ﹤0.01% | 1067 |
|
|
2023
Q3 | – | Sell |
-6
| Closed | -$217 | – | 2082 |
|
|
2023
Q2 | $217 | Sell |
6
-87
| -94% | -$3.15K | ﹤0.01% | 1795 |
|
|
2023
Q1 | $3.46K | Buy |
93
+85
| +1,063% | +$3.16K | ﹤0.01% | 1098 |
|
|
2022
Q4 | $362 | Sell |
8
-2
| -20% | -$91 | ﹤0.01% | 1687 |
|
|
2022
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 1596 |
|
|
2022
Q2 | $1K | Sell |
10
-128
| -93% | -$12.8K | ﹤0.01% | 1600 |
|
|
2022
Q1 | $11K | Buy |
138
+136
| +6,800% | +$10.8K | ﹤0.01% | 815 |
|
|
2021
Q4 | $0 | Sell |
2
-52
| -96% | – | ﹤0.01% | 1989 |
|
|
2021
Q3 | $10K | Buy |
+54
| New | +$10K | ﹤0.01% | 784 |
|
|
2019
Q3 | – | Sell |
-3
| Closed | – | – | 1447 |
|
|
2019
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1437 |
|